MindMed, a biomedical company that develops psychedelic-based products for brain disorders, secured $50 million

MindMed, a biomedical company that develops psychedelic-based products for brain disorders, secured $50 million The company says it will help them in areas such as their Phase 2b study of MM-120 (their optimized form of LSD) for the treatment of generalized anxiety disorder later this year. Read the article on Business Wire > Read More from the Global Wellness News ™

Outdoorsy launches $30 million ‘Oasis Fund’ to capitalize on glamping’s explosive growth

Outdoorsy, in tandem with investors and banking partners, launches $30 million ‘Oasis Fund’ to capitalize on glamping’s explosive growth PRNewswire/ — Outdoorsy, the leading outdoor travel marketplace, today announced the launch of the Oasis Fund – a $30 million dollar initiative dedicated… Read More from the Global Wellness News ™

“Consumers abandon” plant-based meat category citing taste, nutrition, price concerns, Mintel finds

“Consumers abandon” plant-based meat category citing taste, nutrition, price concerns, Mintel finds Between recent acquisition and slumping unit sales, the plant-based meat alternative (PBMA) market faces headwinds as consumers shift to less expensive proteins in the face of economic pressure, though all might not be lost for the category, Mintel shared in its Plant-Based Protein executive summary. Read More from the Global Wellness News ™